🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA June 2026 enforcement update — compounding pharmacies Page 10

FDA June 2026 enforcement update — compounding pharmacies

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 366 replies 55,812 viewsPage 10 of 20
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Oct 3, 2024 at 2:14 PM#46

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: Oct 3, 2024 at 5:14 PM
48 23DadBodDave, AmyNC_wife, SkepticalSean and 45 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Oct 11, 2024 at 10:35 AM#47

Reporting back.

Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Last edited: Oct 11, 2024 at 12:35 PM
47 22Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 44 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Oct 19, 2024 at 6:51 AM#48
RegAffairsDC said:
The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

46 21SleepFixSam, PurityPaulOR, MaxMetOK and 43 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Oct 27, 2024 at 3:02 AM#49
RegAffairsDC said:
The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Oct 27, 2024 at 4:02 AM
45 20rachel_ABQ, traveltech_sara, AttorneyGrant and 42 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Nov 3, 2024 at 11:09 PM#50
RegAffairsDC said:
The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

23 23mike_nyc, VendorMark, COA_Karl and 20 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register